Document is current
Any future updates will be listed below
-
Authors
Li, Aitian https://orcid.org/0009-0003-8229-5227
Wang, Ying
Bai, Haiqing
Xie, Xin
Xu, Beibei
Wang, Yunhan https://orcid.org/0009-0001-8062-2509
Luo, Shengjun
Zhang, Lei https://orcid.org/0009-0007-0527-945X
Zhao, Qitai
Duan, Shichao
Zhao, Huafang
Sun, Yacong
Yuan, Yu-Chieh
Wang, Xinxin
Qiao, Qinghe https://orcid.org/0009-0000-7323-9141
Cui, Jiahui
Zhou, Chenyi
Wang, Huishang
Yang, Lei
Yang, Yang
Si, Longlong https://orcid.org/0000-0002-0504-1659
Zhang, Yi https://orcid.org/0000-0001-9861-4681
- License Information
-
More Information
Article History
Received: 5 September 2025
Accepted: 27 April 2026
First Online: 22 May 2026
Competing interests
: Xin Xie, Haiqing Bai and Yu-Chieh Yuan are employed with their own equity at Xellar Inc., a company that has developed a 3D Organ Chip Culture for drug discovery. The authors declare no other competing interests.
